Skip to content

Your cart is empty

Have an account? Log in to check out faster.

Continue shopping
Used by Mounjaro & Wegovy patients across the UK

The UK's most complete GLP-1 guide

Every Question Answered. Every Side Effect Explained.

  • How GLP-1 medications work
  • Mounjaro vs Wegovy compared
  • Injection instructions
  • Side effects & solutions
  • What to eat on treatment
  • FAQs answered
Get the guide + free tracker — £1.99 →

Free tracker included with every download this week

GLP-1 Medication Guide — 11 chapters, 100+ pages, NHS-aligned with free 52-week weight loss tracker calendar
Free · Instant · No sign-up required

Mounjaro and Inflammation: What You Need to Know

Mounjaro (tirzepatide) is a prescription-only GLP-1 and GIP receptor agonist used for weight management in UK adults. Some people wonder whether Mounjaro can cause or worsen inflammation. The evidence suggests the opposite — clinical data and NHS guidance indicate that tirzepatide may actually help reduce certain inflammatory markers, particularly in people with obesity or type 2 diabetes. This guide explains what the research shows and what to expect.

10,000+ calculations today · NHS-aligned thresholds · 100% free

26%of UK adults are living with obesityNHS Digital, 2023
64%of adults in England are overweight or obeseHealth Survey for England
£6.5bnannual cost of obesity to the NHSPublic Health England
4.7Mpeople in England eligible for weight loss drugsNICE estimates, 2024

Calculate Your BMI Instantly

Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.

What Is BMI and Why Does It Matter?

Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).

While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.

Below 18.5Underweight
18.5 – 24.9Healthy
25 – 29.9Overweight
30+Obese

The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.

How Mounjaro Affects Inflammation and Metabolic Health

Inflammation is often elevated in people with obesity, and excess weight is linked to chronic low-grade inflammatory markers including C-reactive protein (CRP), IL-6, and TNF-alpha. When Mounjaro helps people lose weight, these inflammatory markers often improve alongside metabolic health.

  • Weight loss effect: As body weight decreases, inflammatory markers typically reduce, which can lower cardiovascular risk.
  • Direct metabolic effects: Research suggests tirzepatide may have anti-inflammatory properties beyond weight loss alone, though this is still being studied.
  • Blood sugar control: For people with prediabetes or type 2 diabetes, improved glucose control through Mounjaro can reduce chronic inflammation linked to hyperglycaemia.
  • NHS context: The NHS recognises that weight management and improved metabolic markers — including inflammation reduction — are key health benefits of GLP-1 and dual GIP/GLP-1 medications.

Individual response varies, and your GP can discuss whether Mounjaro might help your specific health situation.

Clinically Backed
Weight Loss

No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.

Get Started →Plans from £144.99/month
AdNew here?
£30OFF
On All Weight Loss Orders
Use Code: FIRST30
GPhC Regulated
Same-day Rx
Next-day Delivery
Genuine Medication

How It Works

Three simple steps to understand your weight and take action.

1Check Your BMI

Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.

2Explore Your Options

If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.

3Track Your Progress

Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.

Free Weight Loss Tools & Guides

Everything you need to understand your weight, explore medication options, and track your progress — completely free.

Does Mounjaro Cause Inflammation As a Side Effect?

Mounjaro's most common side effects are gastrointestinal — nausea, diarrhoea, vomiting, and constipation — rather than inflammatory reactions. Injection site reactions like redness or mild bruising can occur, but these are localised and not systemic inflammation.

Serious allergic reactions (anaphylaxis) are rare but would require immediate medical attention. If you experience swelling of the face, lips, tongue, or throat, seek urgent medical help. For routine side effect concerns, contact your prescriber or GP. Our free GLP-1 weight loss calculator can help you understand potential outcomes at different doses, and tracking your progress with our progress tracker allows you to monitor how you feel throughout treatment.

Mounjaro (Tirzepatide)
  • Dual GIP/GLP-1 receptor agonist
  • Up to 22.5% body weight loss (SURMOUNT-1)
  • Weekly injection, dose escalation over 20+ weeks
  • Available via private prescription in the UK
  • Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
Read our full Mounjaro guide →
Wegovy (Semaglutide)
  • GLP-1 receptor agonist
  • Up to 15–17% body weight loss (STEP trials)
  • Weekly injection, 5-step dose escalation
  • NHS & private prescription available
  • Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Read our full Wegovy guide →

Mounjaro vs Wegovy: Head-to-Head

A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.

FeatureMounjaroWegovy
Drug classDual GIP/GLP-1 agonistGLP-1 agonist
Active ingredientTirzepatideSemaglutide
Avg. weight loss15–22.5%12–17%
Key trialSURMOUNT-1 (2022)STEP 1 (2021)
Max dose15 mg weekly2.4 mg weekly
Escalation period20–32 weeks16–20 weeks
AdministrationWeekly injection (pen)Weekly injection (pen)
NHS availabilityPrivate prescription onlyNHS & private
Approx. private cost£150–£250/month£150–£300/month
Common side effectsNausea, diarrhoea, constipationNausea, vomiting, diarrhoea

Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.

Am I Eligible for Weight Loss Medication?

In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.

Standard eligibility
  • BMI of 30 or above (obese)
  • Age 18 or over
  • No contraindicated conditions
  • Committed to lifestyle changes
With comorbidities
  • BMI of 27 or above
  • Plus type 2 diabetes
  • Or high blood pressure
  • Or obstructive sleep apnoea

Use our BMI calculator to check whether your BMI falls within the eligible range.

How We Built These Tools

Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.

All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.

We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.

Frequently Asked Questions

Common questions about BMI, weight loss medications, and our free UK tools.

Can Mounjaro cause inflammation or inflammatory conditions?

Clinical evidence does not support Mounjaro causing systemic inflammation. In fact, weight loss from Mounjaro typically reduces inflammatory markers like CRP and IL-6. Local injection site reactions can occur but are not systemic inflammation. Always report concerns to your GP or prescriber.

Does tirzepatide help reduce inflammation?

Yes. As Mounjaro helps you lose weight, inflammatory markers often improve. Additionally, better blood sugar control and metabolic health from tirzepatide may reduce chronic inflammation independently. Research is ongoing, but the evidence is encouraging for inflammatory reduction.

Could Mounjaro worsen inflammatory bowel conditions like Crohn's disease?

Mounjaro is not recommended for people with severe gastroparesis or severe gastrointestinal conditions. If you have inflammatory bowel disease, discuss with your GP whether Mounjaro is safe for you, as gastrointestinal side effects could complicate existing conditions.

What inflammatory markers improve with Mounjaro?

Studies show reductions in CRP (C-reactive protein), IL-6, and TNF-alpha — key inflammatory markers linked to cardiovascular risk. These typically improve alongside weight loss and better metabolic control. Your GP can arrange blood tests to monitor these if relevant.

Is Mounjaro available on the NHS in the UK for weight management?

Yes. Mounjaro (tirzepatide) is MHRA-approved and NICE has endorsed it for use within NHS tier 3 specialist weight management services. Access is through referral to specialist services and varies by region. Private prescribing is also available following clinical assessment.

Ready to take control of your weight loss journey?

Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.

Search